Novartis gets USFDA nod for its therapy to treat Berger’s disease
- Posted on April 3, 2025
- By Financial Express
- 4 Views
Novartis gets USFDA nod for its therapy to treat Berger’s disease
IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular inflammation and proteinuria.
